Status:

ACTIVE_NOT_RECRUITING

Radiomics-Based Visualization and Quantitative Validation of IDH1 Heterogeneity in Gliomas

Lead Sponsor:

Mingge LLC

Collaborating Sponsors:

Huashan Hospital

Fudan University

Conditions:

Glioma, Malignant

Computer-Assisted

Eligibility:

All Genders

18-80 years

Phase:

NA

Brief Summary

The goal of this clinical trail is to non-invasively visualise and quantitatively validate an radiomics model of genetic heterogeneity in adult patients with diffuse glioma to help clinicians better g...

Detailed Description

BACKGROUND The WHO 2016 officially introduced molecular markers into the pathological diagnosis of gliomas, marking a step into the era of molecular diagnosis of gliomas. Among them, isocitrate dehyd...

Eligibility Criteria

Inclusion

  • Patients aged 18-70 years, male or female;
  • Patients with complete preoperative magnetic resonance imaging and were initially diagnosed with glioma based on the magnetic resonance imaging results;
  • Patients who were proposed for craniectomy without contraindications to surgery and who had signed an informed consent form by themselves or their proxy;
  • Patients with confirmed diagnosis of glioma by postoperative pathological diagnosis.

Exclusion

  • Patients to be admitted for a simple puncture biopsy;
  • Patients with a combination of serious medical conditions and those who cannot tolerate surgery;
  • Patients with a bleeding tendency or abnormal coagulation function, or those who have not discontinued long-term use of anticoagulants such as aspirin and clopidogrel;
  • Pregnant and breastfeeding women;
  • Patients participate in other clinical trials during the same period.

Key Trial Info

Start Date :

March 15 2019

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 15 2026

Estimated Enrollment :

18 Patients enrolled

Trial Details

Trial ID

NCT05969691

Start Date

March 15 2019

End Date

December 15 2026

Last Update

August 8 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Huashan Hospital, Fudan University

Shanghai, Shanghai Municipality, China, 200433

Radiomics-Based Visualization and Quantitative Validation of IDH1 Heterogeneity in Gliomas | DecenTrialz